Form 4: Ionis Pharmaceuticals Executive Brian Birchler Reports Stock Purchase

EVP Brian Birchler reports purchasing 414 shares of Ionis Pharmaceuticals stock at $28.2115 per share through the employee stock purchase plan.

Summary

• On February 28, 2025, Brian Birchler, EVP, Corp and Development Ops at Ionis Pharmaceuticals, purchased 414 shares of common stock at a price of $28.2115 per share.
• The purchase was made under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan.
• Following the transaction, Birchler directly owns 55,465 shares of Ionis Pharmaceuticals stock.
• These shares may not be sold until August 28, 2025.

Sentiment

Score: 6

Explanation: Neutral sentiment as it reports a routine stock purchase by an executive. It's a positive sign of confidence but not a major event.

Positives

• Executive's participation in the employee stock purchase plan demonstrates confidence in the company.

Industry Context

Executive stock purchases are common and often viewed as a positive signal, indicating management's belief in the company's future prospects. However, the impact is usually minimal unless part of a larger trend or significant transaction.

Stakeholder Impact

• The stock purchase could have a slightly positive impact on shareholder sentiment.

Key Dates